Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -650 | -330 | 2,580 | 2,870 | 2,860 |
| Depreciation Amortization | 6 | 3 | 10 | 0 | 9 |
| Other Working Capital | 240 | 90 | -590 | 0 | -630 |
| Other Operating Activity | 164 | 107 | -4,480 | -5,130 | -4,259 |
| Operating Cash Flow | $-240 | $-130 | $-2,480 | $-2,260 | $-2,020 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -30 | -20 | -20 | -20 | 0 |
| Investing Cash Flow | $-30 | $-20 | $-20 | $-20 | $0 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $0 | $0 | $0 | $0 | $0 |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 150 |
| Beginning Cash Position | 410 | 410 | 2,920 | 2,920 | 2,730 |
| End Cash Position | 130 | 250 | 410 | 640 | 860 |
| Net Cash Flow | $-270 | $-160 | $-2,510 | $-2,280 | $-1,860 |
| Free Cash Flow | |||||
| Operating Cash Flow | -240 | -130 | -2,480 | -2,260 | -2,020 |
| Free Cash Flow | -240 | -130 | -2,480 | -2,260 | -2,020 |